18 results match your criteria: "Mohak Bariatrics and Robotics Center[Affiliation]"

Objective: This study aimed to evaluate the technical variations of one-anastomosis gastric bypass (OAGB) among IFSO-APC and MENAC experts.

Background: The multitude of technical variations and patient selection challenges among metabolic and bariatric surgeons worldwide necessitates a heightened awareness of these issues. Understanding different perspectives and viewpoints can empower surgeons performing OAGB to adapt their techniques, leading to improved outcomes and reduced complications.

View Article and Find Full Text PDF

Background: Obesity is a significant public health issue; new therapies and pharmaceutical approaches to weight management are needed.

Objective: This study assesses weight reduction efficacy in the novel swallow balloon procedure and semaglutide, both promising non-surgical and pharmaceutical options, addressing obesity's critical public health challenge.

Methods: This was a computer-generated, blocked randomisation, double-blind, single-centre study.

View Article and Find Full Text PDF
Article Synopsis
  • Sleeve gastrectomy (SG) is the most popular bariatric surgery globally, but there's concern about the necessity for follow-up surgeries due to issues like insufficient weight loss or complications like GERD.
  • A study involving 46 surgeons from 25 countries was conducted to create guidelines for redo-surgeries after SG, achieving consensus on 62 out of 72 statements regarding best practices.
  • Experts emphasized that a multi-disciplinary evaluation is crucial before any redo-surgery, recommending at least 12 months of medical management and suggesting Roux-en Y gastric bypass as an option for certain complications like symptomatic GERD.
View Article and Find Full Text PDF

Purpose: Bariatric surgery has been proven to be a successful management strategy for morbid obesity, but limited studies exist on its effect on polycystic ovary syndrome (PCOS) in terms of clinical, hormonal, and comorbidities.

Materials And Methods: This is a prospective observational study of 1013 PCOS patients who underwent bariatric surgery from a single high-volume center. Assessment of demographic data and menstrual irregularity as well as hirsutism and comorbidities was done preoperatively 6-month and yearly follow-up, whereas data regarding %TWL and %EWL was taken at follow-up visits conducted at regular intervals of 6 months, and 1, 2, 3, 4, and 5 years following surgery.

View Article and Find Full Text PDF

Purpose: One anastomosis/mini gastric bypass (OAGB/MGB) is up to date the third most performed obesity and metabolic procedure worldwide, which recently has been endorsed by ASMBS. The main criticisms are the risk of bile reflux, esophageal cancer, and malnutrition. Although IFSO has recognized this procedure, guidance is needed regarding selection criteria.

View Article and Find Full Text PDF

Background: Bariatric metabolic surgery is evolving as an option for the treatment of type 2 diabetes mellitus (T2DM) in patients with obesity and T2DM, warranting more studies on the efficacy of bariatric metabolic surgery on T2DM.

Objective: To determine T2DM remission in patients with obesity and T2DM with up to two years follow-up after bariatric metabolic surgery.

Materials And Methods: A retrospective review of prospectively maintained data was undertaken to identify patients who had T2DM and underwent bariatric surgery at a single centre in 2016.

View Article and Find Full Text PDF

Emerging Procedures in Bariatric Metabolic Surgery.

Surg Clin North Am

April 2021

Mohak Bariatrics and Robotics Center, SAIMS Campus, Indore-Ujjain Highway, Indore, Madhya Pradesh, India.

Bariatric/metabolic surgery has emerged as an option for significant and durable weight loss in the treatment of clinically severe obesity; there is increasing demand for bariatric/metabolic surgery worldwide. New procedures have been developed and changed the face of modern bariatric surgery. Gastrointestinal metabolic surgery is a new treatment modality for obesity-related type 2 diabetes mellitus for patients with body mass index greater than 35 kg/m.

View Article and Find Full Text PDF

Trends and progress of bariatric and metabolic surgery in India.

Updates Surg

September 2020

Institute of Minimal Access, Metabolic and Bariatric Surgery, Max Superspecialty Hospital, Saket, New Delhi, India.

Bariatric and metabolic surgery are being performed in India for 2 decades. Aim of this paper is to evaluate the changing clinical trends over the last 5 years and to present the other aspects helmed by Obesity and Metabolic Surgery Society of India (OSSI) to aid the growth of research, education, data management and registry, quality control, insurance-related issues and policy change. OSSI conducts an annual survey to collect data pertaining to numbers of surgical procedures.

View Article and Find Full Text PDF

Background: India is the largest hub for bariatric and metabolic surgery in Asia. OSSI is committed to improve the quality of care and set the standards for its practice in India.

Methods: The first draft of OSSI guidelines was prepared by the secretary, Dr.

View Article and Find Full Text PDF
Article Synopsis
  • Banded sleeve gastrectomy (BSG) and one anastomotic gastric bypass/mini-gastric bypass (OAGB/MGB) are two surgical weight-loss options, with BSG showing better long-term weight maintenance compared to OAGB/MGB over a 6-year follow-up.
  • A retrospective study analyzed data from 68 BSG and 55 OAGB/MGB patients, revealing differences in patient demographics and health conditions, such as higher rates of type 2 diabetes in the BSG group and more hypertension and obstructive sleep apnea in the OAGB/MGB group.
  • While OAGB/MGB had quicker initial weight loss and better resolution rates for diabetes and hypertension, BSG
View Article and Find Full Text PDF

Background: Roux-en-Y gastric bypass (RYGB) is the gold standard in bariatric surgery. One-anastomosis gastric bypass (OAGB) has been reported to have equivalent or better weight loss, with added advantages of being technically easy, amenable to reintervention/reversal, and offering better food tolerance.

Objective: This study was undertaken to compare weight loss, metabolic syndrome outcome, complications, and long-term nutritional outcomes between the 2 procedures.

View Article and Find Full Text PDF

Background: There are few publications on revising sleeve gastrectomy (SG) to one-anastomosis gastric bypass (OAGB).

Objective: This study was undertaken to determine outcomes in terms of weight loss and resolution of co-morbidities in patients who had SG revised to OAGB.

Settings: A high-volume university-affiliated bariatric surgery center in India.

View Article and Find Full Text PDF

Introduction: Functional ability is often impaired as a direct consequence of severe obesity. Bariatric surgery is the most effective treatment for severe obesity.

Objective: To examine the effect of weight loss after bariatric surgery on patients with impaired functional ambulatory abilities due to obesity.

View Article and Find Full Text PDF

Background And Aim: Endoscopic sleeve gastroplasty (ESG) is gaining acceptance as a non-surgical option for the treatment of obesity. However, its role is still not consolidated for all populations and the ideal indications are yet to be determined. We aimed to study the efficacy and safety of ESG in Indian patients.

View Article and Find Full Text PDF

Two modifications of Roux-en-Y gastric bypass (RYGB), one anastomosis gastric bypass (OAGB) and Roux-en-Y banded gastric bypass (BGBP), are gaining popularity in use because the OAGB is reported to be a simpler operation, and the BGBP is reported to have sustained weight loss compared to standard RYGB. A retrospective review and analysis of data comparing outcomes up to 5 years after BGBP and OAGB from a prospectively maintained database of all bariatric metabolic operations in 2012 was performed. Eighty-two patients underwent a BGBP and 90 an OAGB.

View Article and Find Full Text PDF